SCHEMBL4687344

SCHEMBL4687344

CC(=O)OCC(CCC1(CCN2CCC(NC(=O)c3occc3-c3ccc(C)cc3)CC2)CCCCC1)COC(C)=O

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
ALDH1A1 P00352 3/20 0.32
KMT2A Q03164 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
KDM4E B2RXH2 1/20 0.31
CNR1 P21554 1/20 0.31
HTR7 P34969 1/20 0.31
NPC1 O15118 3/20 0.31
RAB9A P51151 2/20 0.31
POLB P06746 1/20 0.31
MEN1 O00255 1/20 0.31
S1PR1 P21453 1/20 0.31
MAPK14 Q16539 1/20 0.31
LMNA P02545 1/20 0.31
SSTR5 P35346 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4690219 0.89 PDE10A (0.35) MAPK14
SCHEMBL4690036 0.89 MCHR1 (0.36) MCHR1L3MBTL1HRH3ALDH1A1KMT2A
SCHEMBL4688285 0.88 L3MBTL1 (0.36) MCHR1L3MBTL1ALDH1A1KMT2ACNR1
SCHEMBL4691461 0.86 MCHR1 (0.38) MCHR1L3MBTL1HRH3ALDH1A1KMT2A
SCHEMBL4690432 0.84 MCHR1 (0.39) MCHR1L3MBTL1HRH3ALDH1A1KMT2A
SCHEMBL4687521 0.84 MCHR1 (0.32) MCHR1L3MBTL1HRH3ALDH1A1KMT2A
SCHEMBL4693190 0.84 L3MBTL1 (0.39) MCHR1L3MBTL1ALDH1A1KMT2ACNR1
SCHEMBL4687554 0.83 L3MBTL1 (0.38) MCHR1L3MBTL1HRH3ALDH1A1KMT2A
SCHEMBL4691029 0.83 L3MBTL1 (0.35) MCHR1L3MBTL1HRH3ALDH1A1KMT2A
SCHEMBL5107097 0.82 L3MBTL1 (0.36) MCHR1L3MBTL1HRH3ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1443046-B1 NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME KYORIN SEIYAKU KK (JP) 2008-12-17 EP disclosed
US-20080194826-A1 Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. 2008-08-14 US disclosed
US-7375115-B2 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. (JP) 2008-05-20 US disclosed
US-20050085508-A1 Novel 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same KYORIN PHARMACEUTICAL CO., LTD. (JP) 2005-04-21 US disclosed
EP-1443046-A1 NOVEL 4-(2FUROYL)AMINOPIPERIDINES, INTERMEDIATES IN SYNTHESIZING THE SAME, PROCESS FOR PRODUCING THE SAME AND MEDICINAL USE OF THE SAME Kyorin Pharmaceutical Co., Ltd. (JP) 2004-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194826-A1 Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same CYP4F2, CYP1A2, CYP4B1 MCHR1 1825/4885L3MBTL1 4882/4885HRH3 3641/4885
US-20050085508-A1 Novel 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same OPRM1, OPRD1, HRH4 MCHR1 187/4885L3MBTL1 3273/4885HRH3 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.